{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f9c37af09dac6250fcd50dc/63fcc6efc42b7a0011d4962d?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"MS Risk Factors and Outcomes","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f9c37af09dac6250fcd50dc/eb8542ff-2f30-4c62-b6ea-5562edd803fe.png?height=200","description":"<p>In her&nbsp;<a href=\"https://elit.dkbmed.com/issues/160\" rel=\"noopener noreferrer\" target=\"_blank\">Expert Commentary</a>, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer data describing the modifiable and nonmodifiable risk factors for developing MS and/or increasing the rate of disease progression and disability.</p><p>Join us for this podcast as Dr. Ward explains how these findings can affect clinical practice to improve overall care of individuals with MS.&nbsp;</p><p><br></p><p>Take our&nbsp;<a href=\"https://elit.dkbmed.com/issues/161/test\" rel=\"noopener noreferrer\" target=\"_blank\">post-test</a>&nbsp;to claim CME credits.</p><p>Read this podcast's companion newsletter <a href=\"https://elit.dkbmed.com/issues/160\" rel=\"noopener noreferrer\" target=\"_blank\">here</a>.</p>","author_name":"DKBmed"}